Meyka AI API is live for developers.Start building.
Advertisement
23andMe Holding Co.

23andMe Holding Co. (MEUSW) Stock Overview

Explore 23andMe Holding Co.’s financial performance, market position, analyst ratings, and future outlook.

MEUSW●NASDAQ
HealthcareMedical - Diagnostics & Research
$1.38
$0.13(8.61%)
U.S. Market opens in 53h 11m
Advertisement

23andMe Holding Co. (MEUSW)

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-0.09
EPS (TTM)N/A
ROE-7.71%
Fundamental Analysis

AI Price Forecasts

1 Month$1.39
3 MonthsN/A
1 Year Target$0.00

MEUSW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of 23andMe Holding Co. (MEUSW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.09 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
-57.54%
All-Time (Max) Change
-57.54%

Contact Information

http://www.23andme.com
800 239 5230
223 N. Mathilda Ave., Sunnyvale, CA, 94086

Company Facts

IPO DateJun 17, 2021
CountryUS

Frequently Asked Questions